Durable response of cutaneous squamous cell carcinoma following high-dose peri-lesional injections of Viscum album extracts – A case report

This publication has 16 references indexed in Scilit:

• Safety of higher dosages of Viscum album L. in animals and humans - systematic review of immune changes and safety parameters
  BMC Complementary and Alternative Medicine, 2011
• A new American Joint Committee on Cancer staging system for cutaneous squamous cell carcinoma: Creation and rationale for inclusion of tumor (T) characteristics
  Journal of the American Academy of Dermatology, 2011
• Review Article: Influence of Viscum album L (European Mistletoe) Extracts on Quality of Life in Cancer Patients: A Systematic Review of Controlled Clinical Studies
  Integrative Cancer Therapies, 2010
• Non-melanoma skin cancer
  The Lancet, 2010
• Treatment of Cutaneous Tumors with Topical 5% Imiquimod Cream
  Clinics, 2009
• Successful Treatment of Metastatic Malignant Melanoma with Viscum album Extract (Iscador ^® M)
  The Journal of Alternative and Complementary Medicine, 2007
• Demographic characteristics, pigmentary and cutaneous risk factors for squamous cell carcinoma of the skin: A case-control study
  International Journal of Cancer, 1998
• The Epidemiology of Non‐Melanoma Skin Cancer: Who, Why and What Can We Do about It
  The Journal of Dermatology, 1995
• Risk of Subsequent Basal Cell Carcinoma and Squamous Cell Carcinoma of the Skin Among Patients With Prior Skin Cancer
  JAMA, 1992
• Phase I trial of murine monoclonal antibody L6 in breast, colon, ovarian, and lung cancer.
  Journal of Clinical Oncology, 1990